Nucala (mepolizumab)

pCPA File Number: 20946
Negotiation Status:
Concluded with an LOI
Indication(s):
Severe Eosinophilic Asthma
Sponsor/Manufacturer:
GlaxoSmithKline
CADTH Project Number:
SR0461-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: